世界の先天性心疾患治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Congenital Heart Disease Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12184 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、129ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、先天性心疾患治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。先天性心疾患治療の種類別市場規模（薬物療法、外科療法）、用途別市場規模（病院・クリニック、診断センター）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・先天性心疾患治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Novartis、Abbott Laboratories、Roche、GSK、Sanofi、Johnson & Johnson、Medtronic、BD、Boston Scientific、Merck、Eli Lilly、Mylan、Sun Pharmaceutical、AstraZeneca ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：薬物療法、外科療法 ・用途別分析2016年-2026年：病院・クリニック、診断センター ・先天性心疾患治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・先天性心疾患治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・先天性心疾患治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・先天性心疾患治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・先天性心疾患治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Congenital Heart Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Congenital Heart Disease Treatment size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Congenital Heart Disease Treatment market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Congenital Heart Disease Treatment market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Medication
Surgical Therapy

Market segment by Application, can be divided into
Hospitals and Clinics
Diagnostic Centers

Market segment by players, this report covers
Pfizer
Novartis
Abbott Laboratories
Roche
GSK
Sanofi
Johnson & Johnson
Medtronic
BD
Boston Scientific
Merck
Eli Lilly
Mylan
Sun Pharmaceutical
AstraZeneca

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease Treatment
1.2 Classification of Congenital Heart Disease Treatment by Type
1.2.1 Overview: Global Congenital Heart Disease Treatment Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Congenital Heart Disease Treatment Revenue Market Share by Type in 2020
1.2.3 Medication
1.2.4 Surgical Therapy
1.3 Global Congenital Heart Disease Treatment Market by Application
1.3.1 Overview: Global Congenital Heart Disease Treatment Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Centers
1.4 Global Congenital Heart Disease Treatment Market Size & Forecast
1.5 Global Congenital Heart Disease Treatment Market Size and Forecast by Region
1.5.1 Global Congenital Heart Disease Treatment Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Congenital Heart Disease Treatment Market Size by Region, (2016-2021)
1.5.3 North America Congenital Heart Disease Treatment Market Size and Prospect (2016-2026)
1.5.4 Europe Congenital Heart Disease Treatment Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Congenital Heart Disease Treatment Market Size and Prospect (2016-2026)
1.5.6 South America Congenital Heart Disease Treatment Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Congenital Heart Disease Treatment Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Congenital Heart Disease Treatment Market Drivers
1.6.2 Congenital Heart Disease Treatment Market Restraints
1.6.3 Congenital Heart Disease Treatment Trends Analysis
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Congenital Heart Disease Treatment Product and Solutions
2.1.4 Pfizer Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Congenital Heart Disease Treatment Product and Solutions
2.2.4 Novartis Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories Congenital Heart Disease Treatment Product and Solutions
2.3.4 Abbott Laboratories Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Laboratories Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Congenital Heart Disease Treatment Product and Solutions
2.4.4 Roche Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 GSK
2.5.1 GSK Details
2.5.2 GSK Major Business
2.5.3 GSK Congenital Heart Disease Treatment Product and Solutions
2.5.4 GSK Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GSK Recent Developments and Future Plans
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi Congenital Heart Disease Treatment Product and Solutions
2.6.4 Sanofi Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Sanofi Recent Developments and Future Plans
2.7 Johnson & Johnson
2.7.1 Johnson & Johnson Details
2.7.2 Johnson & Johnson Major Business
2.7.3 Johnson & Johnson Congenital Heart Disease Treatment Product and Solutions
2.7.4 Johnson & Johnson Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Johnson & Johnson Recent Developments and Future Plans
2.8 Medtronic
2.8.1 Medtronic Details
2.8.2 Medtronic Major Business
2.8.3 Medtronic Congenital Heart Disease Treatment Product and Solutions
2.8.4 Medtronic Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Medtronic Recent Developments and Future Plans
2.9 BD
2.9.1 BD Details
2.9.2 BD Major Business
2.9.3 BD Congenital Heart Disease Treatment Product and Solutions
2.9.4 BD Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 BD Recent Developments and Future Plans
2.10 Boston Scientific
2.10.1 Boston Scientific Details
2.10.2 Boston Scientific Major Business
2.10.3 Boston Scientific Congenital Heart Disease Treatment Product and Solutions
2.10.4 Boston Scientific Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Boston Scientific Recent Developments and Future Plans
2.11 Merck
2.11.1 Merck Details
2.11.2 Merck Major Business
2.11.3 Merck Congenital Heart Disease Treatment Product and Solutions
2.11.4 Merck Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Merck Recent Developments and Future Plans
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business
2.12.3 Eli Lilly Congenital Heart Disease Treatment Product and Solutions
2.12.4 Eli Lilly Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Eli Lilly Recent Developments and Future Plans
2.13 Mylan
2.13.1 Mylan Details
2.13.2 Mylan Major Business
2.13.3 Mylan Congenital Heart Disease Treatment Product and Solutions
2.13.4 Mylan Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Mylan Recent Developments and Future Plans
2.14 Sun Pharmaceutical
2.14.1 Sun Pharmaceutical Details
2.14.2 Sun Pharmaceutical Major Business
2.14.3 Sun Pharmaceutical Congenital Heart Disease Treatment Product and Solutions
2.14.4 Sun Pharmaceutical Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Sun Pharmaceutical Recent Developments and Future Plans
2.15 AstraZeneca
2.15.1 AstraZeneca Details
2.15.2 AstraZeneca Major Business
2.15.3 AstraZeneca Congenital Heart Disease Treatment Product and Solutions
2.15.4 AstraZeneca Congenital Heart Disease Treatment Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 AstraZeneca Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Congenital Heart Disease Treatment Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Congenital Heart Disease Treatment Players Market Share
3.2.2 Top 10 Congenital Heart Disease Treatment Players Market Share
3.2.3 Market Competition Trend
3.3 Congenital Heart Disease Treatment Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Congenital Heart Disease Treatment Revenue and Market Share by Type (2016-2021)
4.2 Global Congenital Heart Disease Treatment Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Congenital Heart Disease Treatment Revenue Market Share by Application (2016-2021)
5.2 Congenital Heart Disease Treatment Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Congenital Heart Disease Treatment Revenue by Type (2016-2026)
6.2 North America Congenital Heart Disease Treatment Revenue by Application (2016-2026)
6.3 North America Congenital Heart Disease Treatment Market Size by Country
6.3.1 North America Congenital Heart Disease Treatment Revenue by Country (2016-2026)
6.3.2 United States Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
6.3.3 Canada Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
6.3.4 Mexico Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Congenital Heart Disease Treatment Revenue by Type (2016-2026)
7.2 Europe Congenital Heart Disease Treatment Revenue by Application (2016-2026)
7.3 Europe Congenital Heart Disease Treatment Market Size by Country
7.3.1 Europe Congenital Heart Disease Treatment Revenue by Country (2016-2026)
7.3.2 Germany Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
7.3.3 France Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
7.3.5 Russia Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
7.3.6 Italy Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Congenital Heart Disease Treatment Revenue by Type (2016-2026)
8.2 Asia-Pacific Congenital Heart Disease Treatment Revenue by Application (2016-2026)
8.3 Asia-Pacific Congenital Heart Disease Treatment Market Size by Region
8.3.1 Asia-Pacific Congenital Heart Disease Treatment Revenue by Region (2016-2026)
8.3.2 China Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8.3.3 Japan Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8.3.4 South Korea Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8.3.5 India Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
8.3.7 Australia Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Congenital Heart Disease Treatment Revenue by Type (2016-2026)
9.2 South America Congenital Heart Disease Treatment Revenue by Application (2016-2026)
9.3 South America Congenital Heart Disease Treatment Market Size by Country
9.3.1 South America Congenital Heart Disease Treatment Revenue by Country (2016-2026)
9.3.2 Brazil Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
9.3.3 Argentina Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Congenital Heart Disease Treatment Revenue by Type (2016-2026)
10.2 Middle East & Africa Congenital Heart Disease Treatment Revenue by Application (2016-2026)
10.3 Middle East & Africa Congenital Heart Disease Treatment Market Size by Country
10.3.1 Middle East & Africa Congenital Heart Disease Treatment Revenue by Country (2016-2026)
10.3.2 Turkey Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
10.3.4 UAE Congenital Heart Disease Treatment Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Congenital Heart Disease Treatment Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Congenital Heart Disease Treatment Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Congenital Heart Disease Treatment Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Congenital Heart Disease Treatment Revenue (USD Million) by Region (2016-2021)
Table 5. Global Congenital Heart Disease Treatment Revenue Market Share by Region (2021-2026)
Table 6. Pfizer Corporate Information, Head Office, and Major Competitors
Table 7. Pfizer Major Business
Table 8. Pfizer Congenital Heart Disease Treatment Product and Solutions
Table 9. Pfizer Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Congenital Heart Disease Treatment Product and Solutions
Table 13. Novartis Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Laboratories Major Business
Table 16. Abbott Laboratories Congenital Heart Disease Treatment Product and Solutions
Table 17. Abbott Laboratories Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Congenital Heart Disease Treatment Product and Solutions
Table 21. Roche Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GSK Corporate Information, Head Office, and Major Competitors
Table 23. GSK Major Business
Table 24. GSK Congenital Heart Disease Treatment Product and Solutions
Table 25. GSK Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Sanofi Corporate Information, Head Office, and Major Competitors
Table 27. Sanofi Major Business
Table 28. Sanofi Congenital Heart Disease Treatment Product and Solutions
Table 29. Sanofi Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Congenital Heart Disease Treatment Product and Solutions
Table 33. Johnson & Johnson Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Medtronic Corporate Information, Head Office, and Major Competitors
Table 35. Medtronic Major Business
Table 36. Medtronic Congenital Heart Disease Treatment Product and Solutions
Table 37. Medtronic Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. BD Corporate Information, Head Office, and Major Competitors
Table 39. BD Major Business
Table 40. BD Congenital Heart Disease Treatment Product and Solutions
Table 41. BD Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Boston Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Boston Scientific Major Business
Table 44. Boston Scientific Congenital Heart Disease Treatment Product and Solutions
Table 45. Boston Scientific Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Merck Corporate Information, Head Office, and Major Competitors
Table 47. Merck Major Business
Table 48. Merck Congenital Heart Disease Treatment Product and Solutions
Table 49. Merck Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 51. Eli Lilly Major Business
Table 52. Eli Lilly Congenital Heart Disease Treatment Product and Solutions
Table 53. Eli Lilly Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Mylan Corporate Information, Head Office, and Major Competitors
Table 55. Mylan Major Business
Table 56. Mylan Congenital Heart Disease Treatment Product and Solutions
Table 57. Mylan Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Sun Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 59. Sun Pharmaceutical Major Business
Table 60. Sun Pharmaceutical Congenital Heart Disease Treatment Product and Solutions
Table 61. Sun Pharmaceutical Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 63. AstraZeneca Major Business
Table 64. AstraZeneca Congenital Heart Disease Treatment Product and Solutions
Table 65. AstraZeneca Congenital Heart Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Congenital Heart Disease Treatment Revenue (USD Million) by Players (2019-2021)
Table 67. Global Congenital Heart Disease Treatment Revenue Share by Players (2019-2021)
Table 68. Breakdown of Congenital Heart Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Congenital Heart Disease Treatment Players Head Office, Products and Services Provided
Table 70. Congenital Heart Disease Treatment Mergers & Acquisitions in the Past Five Years
Table 71. Congenital Heart Disease Treatment New Entrants and Expansion Plans
Table 72. Global Congenital Heart Disease Treatment Revenue (USD Million) by Type (2016-2021)
Table 73. Global Congenital Heart Disease Treatment Revenue Share by Type (2016-2021)
Table 74. Global Congenital Heart Disease Treatment Revenue Forecast by Type (2021-2026)
Table 75. Global Congenital Heart Disease Treatment Revenue by Application (2016-2021)
Table 76. Global Congenital Heart Disease Treatment Revenue Forecast by Application (2021-2026)
Table 77. North America Congenital Heart Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Congenital Heart Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Congenital Heart Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Congenital Heart Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Congenital Heart Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Congenital Heart Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Congenital Heart Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Congenital Heart Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Congenital Heart Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Congenital Heart Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Congenital Heart Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Congenital Heart Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Congenital Heart Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Congenital Heart Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Congenital Heart Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Congenital Heart Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Congenital Heart Disease Treatment Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Congenital Heart Disease Treatment Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Congenital Heart Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Congenital Heart Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Congenital Heart Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Congenital Heart Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Congenital Heart Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Congenital Heart Disease Treatment Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Congenital Heart Disease Treatment Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Congenital Heart Disease Treatment Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Congenital Heart Disease Treatment Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Congenital Heart Disease Treatment Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Congenital Heart Disease Treatment Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Congenital Heart Disease Treatment Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Congenital Heart Disease Treatment Picture
Figure 2. Global Congenital Heart Disease Treatment Revenue Market Share by Type in 2020
Figure 3. Medication
Figure 4. Surgical Therapy
Figure 5. Congenital Heart Disease Treatment Revenue Market Share by Application in 2020
Figure 6. Hospitals and Clinics Picture
Figure 7. Diagnostic Centers Picture
Figure 8. Global Congenital Heart Disease Treatment Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 9. Global Congenital Heart Disease Treatment Revenue and Forecast (2016-2026) & (USD Million)
Figure 10. Global Congenital Heart Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 11. Global Congenital Heart Disease Treatment Revenue Market Share by Region in 2020
Figure 12. North America Congenital Heart Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 13. Europe Congenital Heart Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Asia-Pacific Congenital Heart Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. South America Congenital Heart Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Middle East and Africa Congenital Heart Disease Treatment Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Congenital Heart Disease Treatment Market Drivers
Figure 18. Congenital Heart Disease Treatment Market Restraints
Figure 19. Congenital Heart Disease Treatment Market Trends
Figure 20. Pfizer Recent Developments and Future Plans
Figure 21. Novartis Recent Developments and Future Plans
Figure 22. Abbott Laboratories Recent Developments and Future Plans
Figure 23. Roche Recent Developments and Future Plans
Figure 24. GSK Recent Developments and Future Plans
Figure 25. Sanofi Recent Developments and Future Plans
Figure 26. Johnson & Johnson Recent Developments and Future Plans
Figure 27. Medtronic Recent Developments and Future Plans
Figure 28. BD Recent Developments and Future Plans
Figure 29. Boston Scientific Recent Developments and Future Plans
Figure 30. Merck Recent Developments and Future Plans
Figure 31. Eli Lilly Recent Developments and Future Plans
Figure 32. Mylan Recent Developments and Future Plans
Figure 33. Sun Pharmaceutical Recent Developments and Future Plans
Figure 34. AstraZeneca Recent Developments and Future Plans
Figure 35. Global Congenital Heart Disease Treatment Revenue Share by Players in 2020
Figure 36. Congenital Heart Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 37. Global Top 3 Players Congenital Heart Disease Treatment Revenue Market Share in 2020
Figure 38. Global Top 10 Players Congenital Heart Disease Treatment Revenue Market Share in 2020
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 40. Global Congenital Heart Disease Treatment Revenue Share by Type in 2020
Figure 41. Global Congenital Heart Disease Treatment Market Share Forecast by Type (2021-2026)
Figure 42. Global Congenital Heart Disease Treatment Revenue Share by Application in 2020
Figure 43. Global Congenital Heart Disease Treatment Market Share Forecast by Application (2021-2026)
Figure 44. North America Congenital Heart Disease Treatment Sales Market Share by Type (2016-2026)
Figure 45. North America Congenital Heart Disease Treatment Sales Market Share by Application (2016-2026)
Figure 46. North America Congenital Heart Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 47. United States Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Congenital Heart Disease Treatment Sales Market Share by Type (2016-2026)
Figure 51. Europe Congenital Heart Disease Treatment Sales Market Share by Application (2016-2026)
Figure 52. Europe Congenital Heart Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 53. Germany Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. France Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. United Kingdom Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Russia Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Italy Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Asia-Pacific Congenital Heart Disease Treatment Sales Market Share by Type (2016-2026)
Figure 59. Asia-Pacific Congenital Heart Disease Treatment Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Congenital Heart Disease Treatment Revenue Market Share by Region (2016-2026)
Figure 61. China Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Japan Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South Korea Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. India Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Southeast Asia Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Australia Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. South America Congenital Heart Disease Treatment Sales Market Share by Type (2016-2026)
Figure 68. South America Congenital Heart Disease Treatment Sales Market Share by Application (2016-2026)
Figure 69. South America Congenital Heart Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 70. Brazil Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Argentina Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Middle East and Africa Congenital Heart Disease Treatment Sales Market Share by Type (2016-2026)
Figure 73. Middle East and Africa Congenital Heart Disease Treatment Sales Market Share by Application (2016-2026)
Figure 74. Middle East and Africa Congenital Heart Disease Treatment Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Saudi Arabia Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. UAE Congenital Heart Disease Treatment Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source

---